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Abstract
Louse borne typhus (also called epidemic typhus) was one of man’s major scourges, and epidemics of the disease can be
reignited when social, economic, or political systems are disrupted. The fear of a bioterrorist attack using the etiologic agent
of typhus, Rickettsia prowazekii, was a reality. An attenuated typhus vaccine, R. prowazekii Madrid E strain, was observed to
revert to virulence as demonstrated by isolation of the virulent revertant Evir strain from animals which were inoculated
with Madrid E strain. The mechanism of the mutation in R. prowazekii that affects the virulence of the vaccine was not
known. We sequenced the genome of the virulent revertant Evir strain and compared its genome sequence with the
genome sequences of its parental strain, Madrid E. We found that only a single nucleotide in the entire genome was
different between the vaccine strain Madrid E and its virulent revertant strain Evir. The mutation is a single nucleotide
insertion in the methyltransferase gene (also known as PR028) in the vaccine strain that inactivated the gene. We also
confirmed that the vaccine strain E did not cause fever in guinea pigs and the virulent revertant strain Evir caused fever in
guinea pigs. We concluded that a single nucleotide insertion in the methyltransferase gene of R. prowazekii attenuated the
R. prowazekii vaccine strain E. This suggested that an irreversible insertion or deletion mutation in the methyl transferase
gene of R. prowazekii is required for Madrid E to be considered a safe vaccine.
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Louse borne typhus (also called epidemic typhus) was one of
man’s major scourges from the 1500 s through the mid-20th
century and frequently played a decisive role in wars in Europe
during this period. Thus, it has affected the course of European
history [1]. It has killed millions of people, and the threat of louse
borne typhus is still real. Louse-borne typhus occurs in epidemics
when social, economic, or political systems are disrupted exposing
a large population such as refugees to louse infestation due to lack
of hygiene and reactivation of latent infection associated with the
harsh and stressful conditions. This situation has been observed in
outbreaks of typhus in Burundi, Algeria, Peru, and Russia [2]. In
1997, it was estimated that as many as 100,000 cases of typhus
occurred in the refugee camps of Burundi [2]. Rickettsia
prowazekii, the causative agent of louse borne typhus, may be
also used deliberately by terrorists in a biologic weapon attack.
Rickettsia prowazekii is listed as a Select Agent with rigorous legal
restrictions on its possession and use in research. The former
Soviet Union developed R. prowazekii as a biologic weapon during
the 1930s [3]. During World War II, the Japanese performed
human experiments with rickettsial agents for purposes of biologic
weapon development during their occupation of China [4].
Epidemic typhus is transmitted by the human body louse,
Pediculus humanus corporis. However, the louse is only a vector,
but not a reservoir because the louse dies 5–7 days after infection
with R. prowazekii. Rickettsia prowazekii multiplies in louse gut
epithelial cells, which detach, rupture and release rickettsiae into
the feces and louse hemocoel, killing the insect. The louse feces
containing rickettsiae is scratched into the skin, rubbed into
mucous membranes such as the conjunctiva, or inhaled. Humans
can develop latent infection after acute louse-borne typhus and
serve as reservoirs of R. prowazekii. Rickettsia prowazekii is
subsequently reactivated causing recrudescent typhus fever (Brill-
Zinsser disease) when latently infected persons experience waning
immunity or stressful conditions [5]. Rickettsia prowazekii is also
maintained in a zoonotic cycle involving flying squirrels (Glauc-
omys volans) and their specific fleas and lice in the eastern United
States. Sporadic epidemic typhus occurring in the United States is
transmitted to humans by the flea of flying squirrels [6].
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Lethality of epidemic typhus in the pre-antibiotic era was
usually 15%, and as high as 60%. Even with the availability of
effective rickettsiostatic antibiotic treatment, the mortality rate is
approximately 4% because of late diagnosis and delay in starting
appropriate therapy [2].
After infection, humans develop lifelong immunity to R.
prowazekii infection or become latently infected. Louse borne
typhus is preventable by vaccination using live or dead organisms.
The attenuated Madrid E (E) strain of R. prowazekii, which had
been demonstrated as an effective vaccine, is a spontaneous
laboratory variant that was originally isolated from a typhus
patient in Madrid in 1941 and passed in rapid succession in
embryonated eggs 255 times. The E strain was limited in virulence
for guinea pigs and humans. The E strain is protective and
provided long term immunity against louse borne typhus when
tested as a vaccine during the 1950s and 1960s. Ninety-four
percent (170/181) of immunized persons were protected from
natural infection by epidemic typhus compared to the unvacci-
nated controls in a 14-month period after vaccination [7]. Ninety-
six percent (27/28) of volunteers who were vaccinated with the E
strain and subsequently challenged with Breinl strain at intervals
from 2 months to 36 months remained healthy following
challenge, and 83% (5/6) of the volunteers who were challenged
after 48 to 66 months were protected [8]. However, the E strain
vaccine caused a late reaction in up to 14% of vaccinated persons
9–14 days after inoculation. The late reaction varied from simple
malaise and mild headache to modified typhus characterized by
fever, headache, malaise and occasionally a rash in a small
proportion of subjects [7]. The reason for the late reaction was not
known at the time. In 1971 a virulent revertant strain (Evir) was
isolated by passage of E strain in guinea pigs and/or mice. After
the isolation of Evir strain, E and Evir strains have been compared
for their biological properties and genetic difference. E strain
grows poorly in both human and mouse macrophages, whereas
virulent Evir strain and another virulent strain (Breinl) grow very
well in these cells [9]. A previous study demonstrated that the
patterns of methylation of lysine in the surface protein antigens of
E and Evir were different. The surface antigen, outer membrane
protein B, of the virulent strains Breinl and Evir is extensively
methylated, and that of the avirulent strain E is deficient in protein
methylation [10–13]. Coincidently, we recently demonstrated that
the SAM-methyltransferase gene (smt) was inactivated in E strain
by a single nucleotide insertion, which was absent in the Evir strain
[14]. The important question is whether smt is the only gene
difference between E strain and Evir strain that causes the
reversion of avirulent E strain to virulent Evir strain. To identify
the mechanism of attenuation of E strain, we sequenced the
genome of Evir strain and compared it to the genome of E strain in
the database.
Materials and Methods
Rickettsia prowazekii strain and genomic DNA
preparation
Rickettsiae were cultivated in L929 cell monolayers in 150 cm2
flasks. For preparation of genomic DNA, when 100% of L929 cells
were heavily infected, cells were disrupted by vortexing vigorously
with 4-mm glass beads to release rickettsiae; the cell suspension
was centrifuged at 2006g for 10 minutes to remove unbroken cells
and nuclei. The supernatant was passed sequentially through a
5 mm-syringe filter and a 3 mm-syringe filter. The filtered solution
was centrifuged at 12,1006g for 30 min to collect the rickettsiae.
Rickettsial genomic DNA was extracted using the QIAamp DNA
Mini Kit (Valencia, CA). In order to determine the TCID50,
rickettsial stocks were diluted in 10-fold increments from 1021 to
1029. Each dilution was inoculated onto 4 wells of L929 cell
monolayers in 6-well plates, and infectivity was determined by
examining stained monolayers 12 days later. The TCID50 was
calculated by the Reed-Muench formula.
Animal experiments
All experiments were approved by the Institutional Animal Care
and Use Committee of the University of Texas Medical Branch
(Protocol #: 05-11-074) and conducted in strict compliance with
the NIH Guidelines for the Care and Use of Laboratory Animals
to minimize any pain or suffering of the animals.
We used guinea pigs to test the virulence of R. prowazekii
vaccine E strain and virulent strain Evir because guinea pigs are
susceptible to R. prowazekii infection and develop fever after
infection. Other animals except for monkeys are not susceptible to
R. prowazekii infection. Only animal experiments can determine
the virulence of R. prowazekii strains, which vary from avirulence
to virulence to humans. Therefore, guinea pigs were used in this
study. Twenty one male Hartley strain guinea pigs weighing 250
to 300 grams were randomly divided into seven groups with three
guinea pigs in each group. The first group was inoculated i.p. with
106 uninfected L929 cells (ATCC CCL-1) in which rickettsiae
were cultivated as a negative control. The second, third and fourth
groups were inoculated i.p. with Evir strain at doses of 104, 105,
and 106 organisms, respectively. The fifth, sixth, and seventh
groups were inoculated i.p. with E strain at doses of 104, 105, and
106 organisms, respectively. Body weight and rectal temperature of
the guinea pigs were measured daily from the day of inoculation to
day 13 after inoculation. On day 14 post infection all guinea pigs
were anesthetized by inhaling isofluorane followed by cardiac
puncture to collect blood. The guinea pigs were euthanized by
using CO2 after bleeding.
Genomic DNA sequencing
The Evir strain was sequenced using the Illumina Genome
Analyzer. A subset of reads from which DNA contaminants
Table 1. Mutation in Madrid E strains of R. prowazekii.




E (DOW) T T T
Mutation position was referred to the nucleotide position with the open reading frame of the gene.
doi:10.1371/journal.pone.0113285.t001
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representing L929 cells and low quality reads had been removed,
were de novo assembled into contigs using the Velvet assembler
with optimized parameters. The nucmer algorithm (MUMmer
package, v3.19) was used to align assembled contigs to the parent
Madrid E strain genome and to generate single nucleotide
polymorphisms (SNPs) and insertion or deletion (indel) calls.
Illumina reads were also mapped directly to the parent genome
using BWA, and SNPs were called with Samtools. Variants
detected by both programs were further analyzed and validated by
PCR for both strains, E and Evir. The Evir strain genome
sequence was deposited in GenBank (Access No. PRJNA254815).
Results
DNA sequence
Alignment of the genomes of E strain and Evir strain with
nucmer revealed that the two genomes were perfectly aligned.
There was no large insertion or deletion and no inversion of DNA
sequences.
Initial comparison of the genomes of the Evir strain and the E
strain (DOW) in GenBank revealed 5 SNPs and 26 indels. We
amplified and sequenced the DNA of these SNPs and indels from
strain E (DHW) and Evir strain from our laboratory to confirm the
SNPs and indels. We found that only one nucleotide was different
between Evir strain and E strain (DHW), which was an insertion of
a single A at 732 bp in the SAM methyltransferase gene of the
strain E (DHW) genome and interrupted the SAM methyltrans-
ferase gene near the middle (Table 1). All SNPs and other indels
were not present in the strain E (DHW), suggesting that either the
genome sequence of strain E(DOW) in GenBank, which was one
of the earliest bacterial genomes reported, has errors or the E
strain used for genome sequencing was different from E strain
(DHW) in our laboratory.
To determine whether the SNPs and indels in E strain (DOW)
genomic sequence in GenBank were genuine or caused by
sequence errors, we acquired a strain E (DOW) that was used
for the original R. prowazekii genomic sequence from Dr. David
Wood’s laboratory at the University of South Alabama. We
amplified and sequenced all SNPs and indels of strain E (DOW).
In addition to the insertion of a T at 732 bp in the SAM
methyltransferase gene, strain E (DOW) has two additional
nucleotide insertion mutations, which interrupted genes Rp061
and recO, respectively (Table 1). An insertion of a T at position 64
occurred in Rp061, which introduced a premature stop codon,
resulting in a peptide that lacks the first 19 amino acids. Rp061 is a
conserved protein in Rickettsia and is not found in other bacteria.
The Rickettsia recO encoded a DNA repair protein. The insertion
of a T at position 326 of recO in R. prowazekii also interrupted the
gene. Other SNPs which were different between Evir strain and E
strain (DOW) in GenBank were not identified in strain E (DHW)
and strain (DOW). It suggested that these differences were most
likely caused by sequence errors in the GenBank sequence
(Accession No: AJ235269.1) (Table 2). The genotype of strain E
(DHW) was smt2, recO+, rp061+ and the genotype of strain E
(DOW) was smt2, recO2, rp0612.
Animal experiment
All guinea pigs inoculated with 105 and 106 organisms of Evir
strain developed a fever. After inoculation with a high dose (106
organisms) of Evir strain, one guinea pig had fever from day 5 to
day 10, one guinea pig had fever from day 6 to day 11, and one
had fever on days 7 and 8. With the medium dose (105 organisms)
of Evir strain, all 3 guinea pigs had fever from day 8 to day 11.
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pigs had a fever from day 8 to 10 after inoculation. The guinea
pigs inoculated with the highest dose of Evir strain had a shorter
incubation period and a longer period of fever (Figures 1 and 2).
In contrast, regardless of the dose (from 104 to 106), no guinea pig
inoculated with strain E (DHW) developed fever, and the growth
rate of guinea pigs as determined by body weight was not affected
by strain E (DHW) infection compared to L929 cell mock-infected
guinea pigs. During the febrile period, the growth rate of the
guinea pigs inoculated with 105 and 106 organisms of strain Evir
was significantly slower than the guinea pigs inoculated with strain
E (DHW) or L929 cells. This result confirmed that strain E (DHW)
was avirulent and strain Evir was virulent for guinea pigs.
Discussion
We sequenced the genome of R. prowazekii strain Evir and
compared it with the genome sequence of strain E (DOW) in
GenBank and identified 31 insertions, deletions and SNPs between
Evir and E strain (DOW). We sequenced all insertion, deletion and
SNPs in strain E (DHW), which we had in our laboratory. We
found only one mutation was truly a mutation in strain E (DHW).
The mutation interrupted smt into two open reading frames,
which was designated as rp027 and rp028 previously [15]. We
were curious whether the remaining differences between Evir and
E (DOW) strain were genuine or caused by sequence errors in the
GenBank sequence. We amplified and sequenced all SNPs and
indels in a prototype strain E (DOW), which was used for
Figure 1. Body weight changes after infection with R. prowazekii strain E strain (DHW) and strain Evir at 104, 105, or 106 organisms.
L929 cell suspension was used as control.
doi:10.1371/journal.pone.0113285.g001
Figure 2. Body temperature changes after infection with R. prowazekii strain E (DHW) and strain Evir at 106 (E or Evir), 105 (E1:10 and
Evir 1:10), or 104 (E1:100 and Evir 1:100) organisms. L929 cell suspension was used as control.
doi:10.1371/journal.pone.0113285.g002
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generating the genome sequence of R. prowazekii in GenBank
(AJ235269.1). Sequence of strain E (DOW) demonstrated that
three nucleotides were different between strains Evir and E
(DOW), in addition to smt, two additional single nucleotide
mutations interrupted recO, and rp061 in strain E (DOW). The
recO and rp061 mutations have been found in E strain from other
laboratory previously [16]. recO and rp061 mutations were not
identified in all strains of R. prowazekii sequenced.
E strain is avirulent for humans and animals, but passages in
animals selected a more virulent strain, Evir. We do not know the
origins of strain E (DHW) and strain E (DOW). It is most likely
that strain E first acquired the mutation in smt and further
passages led to accumulation of more mutations such as recO and
rp061.
Mild typhus observed in 14% of vaccinated humans was most
likely caused by a mixed population of virulent and avirulent
strains. Previously we demonstrated that the methyltransferase
gene is inactivated by a frame shift mutation in E strain, but the
mutation does not exist in the virulent strain Evir [14]. To
determine whether mutation in smt determines the attenuation of
E strain, we evaluated the virulence of E (DHW) strain in guinea
pigs. We demonstrated that E strain (DHW) was avirulent for
guinea pigs, but Evir strain is virulent for guinea pigs. After we
found that strain E (DHW) and strain E (DOW) were genetically
different, we further tested the virulence of E (DOW) in guinea
pigs. As expected that E (DOW) also did not cause fever or body
weight loss in guinea pigs (data not shown). Since the only three
genes different between Evir and E (DOW) and one gene (smt)
different between strain Evir and strain E (DHW), we reasoned
that the reverse mutation in smt determined the virulence of R.
prowazekii. As smt encodes a methyltransferase, these results
clearly indicate that the methyltransferase gene is critical for the
virulence of R. prowazekii and the attenuation of E strain might be
caused by inactivation of SAM-methyltransferase. It is apparent
that SAM-methyltransferase is a virulence factor and deficiency of
this enzyme may affect the growth or survival of Rickettsia inside
the animal host.
A previous study demonstrated that avirulent E strain and Erus
had a 12 nucleotide deletion in rp827, but all virulent strains
including Breinl, Rp22, and Evir had no deletion in rp827. In
contrast, we found that a 12 nucleotide stretch was deleted from all
three strains derived from E strain including Evir, strain E (DOW),
and E strain (DHW). It seems highly improbable to have a reverse
mutation that inserts 12 nucleotides in rp827 in Evir strain to
restore the mutated gene.
Conclusions
We concluded that a single nucleotide insertion in the
methyltransferase gene smt attenuates R. prowazekii vaccine strain
E, and a reversion mutation makes the revertant strain Evir. It
suggests that a safe and irreversible vaccine of R. prowazekii can be
achieved by genetic deletion of nucleotides of the smt gene of
Rickettsia prowazekii E strain.
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